Carnitine palmitoyltransferase 1C promotes EMT-associated cisplatin resistance in non-small cell lung cancer cells
Objective: Lung cancer is the most common cause of cancer-related deaths worldwide. Platinum-based chemotherapy is one of the main treatment options for patients with non-small cell lung cancer (NSCLC) but the effectiveness of chemotherapy is encumbered by drug resistance. Therefore, understanding t...
Saved in:
| Main Authors: | Renjie Chen, Jiahui Wang, Shuoyu Huang, Xuefeng Hu, Xinran He, Tiange Zhang, Yunhan Hu, Huijun Wei, Sihui Nian, Yushu Huang, Zhihao Wu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
China Anti-Cancer Association
2025-01-01
|
| Series: | Cancer Biology & Medicine |
| Subjects: | |
| Online Access: | https://www.cancerbiomed.org/content/22/1/48 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Regulation of EMT-MET and chemoresistance by the Lc3Cer-synthase B3GNT5
by: Laura E. Clark, et al.
Published: (2025-08-01) -
FXR promotes clear cell renal cell carcinoma carcinogenesis via MMP-7-regulated EMT pathway
by: Jiachen Liu, et al.
Published: (2024-11-01) -
Recurrent rhabdomyolysis caused by palmitoyltransferase II (CPT-2) deficiency but complete normal acylcarnitine profile: A patient presentation and review of the literature
by: Chih-Hsuan Lu, et al.
Published: (2024-12-01) -
Autophagy inhibition improves sensitivity to the multi-kinase inhibitor regorafenib in preclinical mouse colon tumoroids
by: Giulia Agostini, et al.
Published: (2025-07-01) -
Prognostic value of EMT-related genes and immune cell infiltration in thyroid carcinoma
by: Shuping Wu, et al.
Published: (2024-11-01)